Marijuana and Medical Marijuana References
  • ADHD books published by NorthEast Books & Publishing, by Association for Youth, Children and Natural Psychology
  • ADHD books published by NorthEast Books & Publishing, by Association for Youth, Children and Natural Psychology


This website is certified by Health On the Net Foundation. Click to verify. Certificate validity:
04 Apr 2017 - Apr 2018

In the Spotlight

Psychiatric Labeling Labeling People
Adventure Therapy
Best Children's Books List (200+)
Positive Steps and Interventions
Arts Therapy
Self Help Psychology - 16 Keys
Self Help Mental Health
Depression Self Help
Music Psychology
Music Therapy
Poetry Therapy
Coaching and Mentoring
Green Therapy
Adventure Therapy
Biofeedback - Neurofeedback
Professional Therapies
Psychological Disorders
Help for Depression
About Bipolar Disorder
Borderline Personality Disorder
Dialectical Behavior Therapy
Treatment of Anxiety
Overcoming Panic Attacks - Naturally
Sleep problems Sleep Remedies
Obsessive Compulsive DisorderOCD
Eating Disorders Info
Schizophrenia Help
Oppositional Defiant Disorder
Conduct Disorder
Treatment of Epilepsy
Children and Youth
Autism in Children
Child Abuse Information
Positive Parenting - 24 Steps
School Psychology, Education
Sport Psychology
Internet Safety
Pornography Effects - Addiction, Help
Suicide Prevention

ADHD Books - English / Spanish - (offsite) NorthEast Books & Publishing

ADHD Book - Amazon


Please send any suggestions and comments
The Association for Youth, Children and Natural Psychology is a non-profit New Jersey corporation and a
501(c)3 non-profit corporation

This page:

Marijuana use in the United States, how widespread? What are the effects of marijuana on the mind? How does marijuana use impact health? What are the uses of medical marijuana? What are the benefits and risks of medical marijuana?

See also:

Adolescent Psychology

The History of Opium

Selecting the Right Drug and Alcohol Rehab

Making a Success of Drug and Alcohol Rehab

Cannabiz: The Explosive Rise of the Medical Marijuana Industry by John Geluardi

Understanding Marijuana: A New Look at the Scientific Evidence by Mitch Earleywine

Dying to Get High: Marijuana as Medicine by Wendy Chapkis, Richard Webb

The Science of Marijuana by Leslie L. Iversen

Marijuana Myths Marijuana Facts: A Review Of The Scientific Evidence by Lynn Zimmer (Author), John P. Morgan

Legalizing Drugs: Crime Stopper or Social Risk? (USA Today's Debate: Voices and Perspectives) by Margaret J. Goldstein

Cannabis And Young People: Reviewing the Evidence by -Richard Jenkins


Page updated: November 13, 2015

Marijuana and Medical Marijuana References

1. Johnston, L.D.; O'Malley, P.M.; and Bachman, J.G. Monitoring the Future; National Results on Adolescent Drug Use, Overview and Key Findings, 2004. NIH Pub. No. 05-5506. Bethesda, MD: NIDA, NIH, DHHS, 2005.

2. Substance Abuse and Mental Health Services Administration. Results from the 2003 National Survey on Drug Use and Health: National Findings. NSDUH Series H-25. DHHS Pub. No. (SMA) 04-3964. Rockville, MD: DHHS, 2004.

3. ElSohly, M.A. Quarterly report: Potency monitoring project. February 2004, unpublished.

4. Tashkin, D.P. Pulmonary complications of smoked substance abuse. West J Med 152:525-530, 1990.

5. Sarafian, T.A.; Magallanes, J.A.; Shau, H.; Tashkin, D.; and Roth, M.D. Oxidative stress produced by marijuana smoke. An adverse effect enhanced by cannabinoids. Am J Respir Cell Mol Biol 20(6):1286-1293, 1999.

6. Roth, M.D.; Arora, A.; Barsky, S.H.; Kleerup, E.C.; Simmons, M.; and Tashkin, D.P. Airway inflammation in young marijuana and tobacco smokers. Am. J. Respir Crit Care Med 157(3):928-937, 1998.

7. Heishman, S.J.; Arasteh, K; and Stitzer, M.L. Comparative effects of alcohol and marijuana on mood, memory, and performance. Pharmacol Biochemical Behavior 58(1):93-101, 1997.

8. Fletcher, J.M.; Page, J.B.; Francis, D.J.; Copeland, K.; Naus, M.J.; Davis, C.M.; Morris, R.; Krauskopf, D.; and Satz, P. Cognitive correlates of chronic cannabis use in Costa Rican men. Archives of General Psychiatry 53:1051-1057, 1996.

9. Block, R.I., and Ghoneim, M.M. Effects of chronic marijuana use on human cognition. Psychopharmacology 100(1-2): 219-228, 1993.

10. Graham, A.W.; Schultz, T.K.; and Wilford, B.B. (eds.). Principles of Addiction Medicine, 2nd Edition. Chevy Chase, MD: American Society of Addiction Medicine, Inc., 1998.

11. Ameri, A. The effects of cannabinoids on the brain. Prog Neurobiol 58(4):315-348, 1999.

12. Patrick, G., and Struve, F.A. Reduction of auditory P50 gating response in marihuana users: further supporting data. Clin Electroencephalogr 31(2):88-93, 2000.

13. Srivastava, M.D.; Srivastava, B.I.; and Brouhard, B. Delta-9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells. Immunopharmacology 40(3):179-185, 1998.

14. Zhu, L.X.; Sharma, M.; Stolina, S.; Gardner, B.; Roth, M.D.; Tashkin, D.P.; and Dubinett, S.M. Delta-9 tetrahydrocannabinol inhibits antitumor immunity by a CB-2 receptor-mediated, cytokine dependent-pathway. J Immunology 165(1):373-380, 2000.

15. Gilman, A.G.; Rall, T.W.; Nies, A.S.; and Taylor, P. (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th Edition. New York: Pergamon Press, 1998.

16. Adams, I.B.; and Martin, B.R. Cannabis: Pharmacology and toxicology in animals and humans. Addiction 91:1585-1614, 1996.

17. Zhang, Z.-F.; Morgenstern, H.; Spitz, M.R.; Tashkin, D.P.; Yu, G.-P.; Marshall, J.R.; Hsu, T.C; and Schantz, S.P. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiology, Biomarkers & Prevention 6:1071-1078, 1999.

18. Brook, J.S.; Rosen, Z.; Brook, D.W. The effect of early marijuana use on later anxiety and depressive symptoms. NYS Psychologist January:35-39, 2001.

19. Wilson, W.; Mathew, R.; Turkington, T.; Hawk, T.; Coleman, R.E.; and Provenzale, J. Brain morphological changes and early marijuana use: A magnetic resonance and positron emission tomography study. J Addict Dis 19(1):1-22, 2000.

20. Brook, J.S.; Balka, E.B.; and Whiteman, M. The risks for late adolescence of early adolescent marijuana use. Am J Public Health 89(10):1549-1554, 1999.

21. Community Epidemiology Work Group. Epidemiologic Trends in Drug Abuse, Vol. II, Proceedings of the Community Epidemiology Work Group. December 2003. NIH Pub. No. 04-5365. Bethesda, MD: NIDA, NIH, DHHS, 2004.

22. ElSohly, M.A.; Ross, S.A.; Mehmedic, Z.; Arafat, R.; Yi, B.; and Banahan, B. Potency trends of delta-9-THC and other cannabinoids in confiscated marijuana from 1980-1997. Journal of Forensic Sciences 45(1):24-30, 2000.

23. Substance Abuse and Mental Health Services Administration. Results from the 2003 National Survey on Drug Use and Health: National Findings. NSDUH Series H-25. DHHS Pub. No. (SMA) 04-3964. Rockville, MD: SAMHSA, 2004.

24. Johnston, L.D.; O'Malley, P.M.; and Bachman, J.G. Monitoring the Future: National Results on Adolescent Drug Use, Overview and Key Findings, 2004. NIH Pub. No. 05-5506. Bethesda, MD: NIDA, NIH, DHHS, 2005.

25. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Emergency Department Trends from DAWN: Final Estimates 1995-2002. DAWN Series D-24; DHHS Pub. No. (SMA) 03-3780. Rockville, MD: SAMHSA, 2003.

26. National Institute of Justice, Arrestee Drug Abuse Monitoring Program. Preliminary Data on Drug Use and Related Matters Among Adult Arrestees & Juvenile Detainees, 2002. Washington, DC: U.S. Department of Justice, 2002.

27. Herkenham, M.; Lynn, A.; Little, M.D.; Johnson, M.R.; Melvin, L.S.; de Costa, B.R.; and Rice K.C. Cannabinoid receptor localization in the brain. Proc Natl Acad Sci, USA. 87(5):1932-1936, 1990.

28. Ohlsson, A.; Lindgren, J.E.; Wahlen, A.; Agurell, S.; Hollister, L.E.; and Gillespie, H.K. Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin Pharmacol Ther 28(3):409-416, 1980.

29. Foltin, R.W.; Fischman, M.W; Pedroso, J.J.; and Pearlson, G.D. Marijuana and cocaine interactions in humans: cardiovascular consequences. Pharmacol Biochem Behav 28(4):459-464,1987.

30. Chen, J.P.; Paredes, W.; Li, J.; Smith, D.; Lowinson, J.; and Gardner, E.L. Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology 102:156-162, 1990.

31. French, E.D. Delta-9 THC excites ret VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors. Neurosci Lett 226:159-162, 1997.

32. Leshner, A.I., and Koob, G.F. Drugs of abuse and the brain. Proc Assoc Amer Physicians 111(2):99-108, 1999.

33. Pope, H.G., and Yurgelun-Todd, D. The residual cognitive effects of heavy marijuana use in college students. JAMA 275(7):521-527, 1996.

34. Mason, A.P., and McBay, A.J. Ethanol, marijuana, and other drug use in 600 drivers killed in single-vehicle crashes in North Carolina, 1978-1981. J Forensic Sci 29(4):987-1026, 1984.

35. Williams, A.F.; Peat, M.A.; Crouch, D.J.; Wells, J.K.; and Finkle, B.S. Drugs in fatally injured young male drivers. Public Health Report 100(1):19-25, 1985.

36. Cimbura, G.; Lucas, D.M.; Bennett, R.C.; and Donelson, A.C. Incidence and toxicological aspects of cannabis and ethanol detected in 1,394 fatally injured drivers and pedestrians in Ontario (1982-1984). J Forensic Sci 35(5):1035-1041, 1990.

37. National Highway Traffic Safety Administration (NHTSA) Notes. Marijuana and alcohol combined severely impede driving performance. Annals of Emergency Medicine 35(4):398-399, 2000.

38. Ford, D.E.; Vu, H.T.; and Anthony, J.C. Marijuana use and cessation of tobacco smoking in adults from a community sample. Drug and Alcohol Dependence 67:243-248, 2002.

39. Polen, M.R; Sidney, S.; Tekawa, I.S.; Sadler. M.; and Friedman, G.D. Health care use by frequent marijuana smokers who do not smoke tobacco. West J Med 158:596-601, 1993.

40. Sridhar, K.S.; Raub, W.A.; Weatherby, N.L., Jr.; Metsch, L.R.; Surratt, H.L.; Inciardi, J.A.; Duncan, R.C.; Anwyl, R.S.; and McCoy, C.B. Possible role of marijuana smoking as a carcinogen in the development of lung cancer at a young age. Journal of Psychoactive Drugs 26(3):285-288, 1994.

41. Hoffman, D.; Brunnemann, K.D.; Gori, G.B.; and Wynder, E.E.L. On the carcinogenicity of marijuana smoke. In: V.C. Runeckles, ed., Recent Advances in Phytochemistry. New York: Plenum, 1975.

42. Cohen, S. Adverse effects of marijuana: Selected issues. Annals of the New York Academy of Sciences 362:119-124, 1981. 43. Klein, T.W.; Newton, C.; and Friedman, H. Microbial infections, immunomodulation, and drugs of abuse. Clin Microbiol Rev 2003, April 16 (2):209-19.

44. Mittleman, M.A.; Lewis, R.A.; Maclure, M.; Sherwood, J.B.; and Muller, J.E. Triggering myocardial infarction by marijuana. Circulation 103:2805-2809, 2001.

45. Lynskey, M.; and Hall, W. The effects of adolescent cannabis use on educational attainment: A review. Addiction 95(11):1621-1630, 2000.

46. Kandel, D.B., and Davies, M. High school students who use crack and other drugs. Arch Gen Psychiatry 53(1):71-80, 1996.

47. Rob, M.; Reynolds, I.; and Finlayson, P.F. Adolescent marijuana use: Risk factors and implications. Aust NZ J Psychiatry 24(1):45-56, 1990.

48. Zwerling, C.; Ryan, J.; and Orav, E.J. The efficacy of preemployment drug screening for marijuana and cocaine in predicting employment outcome. JAMA; 264 (20): 2639-43, 1990.

49. Budney, A.J.; Moore, B.A.; Vandrey, R.G.; and Hughes, J.R. The time course and significance of cannabis withdrawal. J Abnorm Psychol 112(3):393-402, 2003.

50. Brook, J.S.; Cohen, P.; and Brook, D.W. Longitudinal study of co-occurring psychiatric disorders and substance use. J Acad Child and Adolescent Psych 37(3):322-330, 1998.

51. Pope, H.G.; Gruber, A.J.; Hudson, J.I.; Huestis, M.A.; and Yurgelun-Todd. D. Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry 58(10):909-915, 2001.

52. Scheier, L.M., and Botvin, G.J. Effects of early adolescent drug use on cognitive efficacy in early-late adolescence: A developmental structural model. Journal of Substance Abuse 7(4):397-404, 1996.

53. Gruber, A.J.; Pope, H.G.; Hudson, J.I.; and Yurgelun-Todd, D. Attributes of long-term heavy cannabis users: a case-control study. Psychological Medicine 33:1415-1422, 2003.

54. Lester, B.M., and Dreher, M. Effects of marijuana use during pregnancy on newborn crying. Child Development 60(23/24):764-771, 1989.

55. Fried, P.A. The Ottawa prenatal prospective study (OPPS): Methodological issues and findings. It's easy to throw the baby out with the bath water. Life Sciences 56:2159-2168, 1995.

56. Fried, P.A.; and Smith, A.M. A literature review of the consequences of prenatal marihuana exposure: An emerging theme of a deficiency in aspects of executive function. Neurotoxicology and Teratology 23(1): 1-11, 2001.

57. Substance Abuse and Mental Health Services Administration. Results from the 2003 National Survey on Drug Use and Health: National Findings. NSDUH Series H-25. DHHS Pub. No. (SMA) 04-3964. Rockville, MD: SAMHSA, 2004.

58. Substance Abuse and Mental Health Services Administration. Treatment Episode Data Set (TEDS): 1992-2002, National Admissions to Substance Abuse Treatment Services. DASIS Series: S-23, DHHS Pub. No. (SMA) 04-3965. Rockville, MD: DHHS, 2004.

59. Haney, M.; Ward, A.S.; Comer, S.D.; Foltin, R.W.; and Fischman, M.W. Abstinence symptoms following smoked marijuana in humans. Psychopharmacology 141:395-404, 1999.

60. Budney, A.J.; Hughes, J.R.; Moore, B.A.; and Novy, P.L. Marijuana abstinence effects in marijuana smokers maintained in their home environment. Arch Gen Psychiatry 58:917-924, 2001.

61. Kouri, E.M.; Pope, H.G.; and Lukas, S.E. Changes in aggressive behavior during withdrawal from long-term marijuana use. Psychopharmacology 143:302-308, 1999.

62. Lynskey, M.T.; Heath, A.C.; Bucholz, K.K.; Slutske, W.S.; Madden, P.A.F.; Nelson, E.C.; Statham, D.J.; and Martin, N.G. Escalation of drug use in early-onset cannabis users vs. co-twin controls. JAMA 289(4):427-433, 2003.

63. Steinberg, K.L.; Roffman, R.A.; Carroll, K.M.; Kabela, E.; Kadden, R.; Miller, M.; and Duresky, D. The Marijuana Treatment Project Research Group. Tailoring cannabis dependence treatment for a diverse population. Addiction 97(Suppl 1):135-142, 2002.

64. Stephens, R.S.; Roffman R.A.; and Curtin, L. Comparison of extended versus brief treatments for marijuana use. J Consult Clin Psychol 68(5):898-908, 2000.

65. Budney, A.J.; Higgins, S.T.; Radonovich, K.J.; and Novy PL. Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J Consult Clin Psychol 68(6):1051-1061, 2000.

66. Heyser, C.J.; Hampson, R.E.; and Deadwyler, S.A. Effects of delta-9-tetrahydrocannabinol on delayed match to sample performance in rats: Alterations in short-term memory associated with changes in task-specific firing of hippocampal cells. Journal of Pharmacology & Experimental Therapeutics 264(1):294-307, 1993.

67. Landfield, P.W.; Cadwallader, L.B.; and Vinsant, S. Quantitative changes in hippocampal structure following long exposure to delta-9-tetrahydrocannabinol: Possible mediation of glucocorticoid systems. Brain Res 443(1-2):47-62, 1988. 68. Eldridge, J.C.; Murphy, L.L.; and Landfield, P.W. Cannabinoids and the hippocampal glucocorticoid receptor: recent findings and possible significance. Steroids 56:226-230, 1991.

69. Landfield, P.W.; Waymire, J.C.; and Lynch, G. Hippocampal aging and adrenocorticoids: quantitative correlations. Science 202:1098-1101, 1978.

70. Walker, M.J.; Huang, S.M.; Strangman, N.M.; Tsou, K.; and Sanudo-Pena, M.C. Pain modulation by the release of the endogenous cannabinoid anandamide. Proceedings of the National Academy of Sciences 96(21):12198-12203, 1999.

71. Wenger, T.; Toth, B.E.; Juaneda, C.; Leonardelli, J.; and Tramu, G. The effects of cannabinoids on the regulation of reproduction. Life Sci 65(6-7):695-701, 1999.

72. Maldonado, R.; and Rodriguez de Fonseca, F. Cannabinoid addiction: Behavioral models and neural correlates. J Neuroscience 22(9):3326-3331, 2002.

73. Breivogel, C.S.; Scates, S.M.; Beletskaya, I.O.; Lowery, O.B.; Aceto, M.D.; and Martin, B.R. The effects of delta-9 tetrahydrocannabinol physical dependence on brain cannabinoid receptors. Euro J Pharmacology 459:139-150, 2003.

74. Piomelli, D.; Giuffrida, A.; Calignano, A.; and Rodriguez de Fonseca, F. The endocannabinoid system as a target for therapeutic drugs. TIPS 21:218-224, 2000.

75. Marijuana, Medical Use, (2010.) NORML - Working to Reform Marijuana Laws.

76. Fried, P.A.; and Makin, J.E. Neonatal behavioural correlates of prenatal exposure to marihuana, cigarettes and alcohol in a low risk population. Neurotoxicology and Teratology 9(1):1-7, 1987

77. Johson, Kirk, (November 7, 2010). Where Marijuana Is a Point of Pride. New York Times.

Source: The National Institute on Drug Abuse (NIDA)
U.S. Department of Health and Human Services.

Pages Related to Marijuana Mental Effects

Marijuana and Medical Marijuana Marijuana, Depression, Schizophrenia and Suicide Risk

Marijuana Research, School and Grades, Addiction, Pregnancy (on-site)

Marijuana Mental Effects

Quit smoking help - How to Quit Smoking